IRadimed Corporation (IRMD)
NASDAQ: IRMD · IEX Real-Time Price · USD
43.67
+0.23 (0.53%)
Jul 2, 2024, 4:00 PM EDT - Market closed
IRadimed Market Cap
IRadimed has a market cap or net worth of $553.05 million as of July 2, 2024. Its market cap has decreased by -8.53% in one year.
Market Cap
553.05M
Enterprise Value
509.86M
1-Year Change
-8.53%
Ranking
Category
Stock Price
$43.67
Market Cap Chart
Since July 16, 2014, IRadimed's market cap has increased from $100.50M to $553.05M, an increase of 450.29%. That is a compound annual growth rate of 18.79%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jun 7, 2024 | 538.20M | -10.06% |
Dec 29, 2023 | 598.40M | 68.33% |
Dec 30, 2022 | 355.50M | -37.66% |
Dec 31, 2021 | 570.30M | 103.90% |
Dec 31, 2020 | 279.70M | 4.17% |
Dec 31, 2019 | 268.50M | 0.37% |
Dec 31, 2018 | 267.50M | 67.29% |
Dec 29, 2017 | 159.90M | 34.48% |
Dec 30, 2016 | 118.90M | -61.68% |
Dec 31, 2015 | 310.30M | 122.44% |
Dec 31, 2014 | 139.50M | 38.81% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
SIGA Technologies | 546.22M |
Clover Health Investments | 546.08M |
OmniAb | 543.46M |
Travere Therapeutics | 542.80M |
Heron Therapeutics | 542.35M |
PepGen | 537.15M |
Applied Therapeutics | 533.63M |
Adaptive Biotechnologies | 532.00M |